<DOC>
	<DOCNO>NCT02188758</DOCNO>
	<brief_summary>The goal study identify chemical compound blood sputum ( i.e. , biomarkers ) associate objective measurement health status patient cystic fibrosis ( CF ) . This study build upon observation blood level hepcidin-25 , protein regulate body us store iron , vary CF pulmonary exacerbation ( CFPE ) .</brief_summary>
	<brief_title>Biomarkers Iron Homeostasis Responses Cystic Fibrosis Pulmonary Exacerbation ( CFPE ) Treatment</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Hepcidins</mesh_term>
	<criteria>Inclusion Criteria ( require screen visit ) : Diagnosis CF confirm history positive chloride sweat test and/or CFTR mutation analysis ; History consistent sputum production occasion ; FEV1 % great equal 75 % best measurement previous 6 month ; 1 hospitalization CFPE treatment intravenous antibiotic within previous year ; Absence CFPE ( i.e. , Akron Pulmonary Exacerbation Score &lt; 5 ) ; Not admit hospital within previous 3 week ; Body weight great equal 75 % best measurement previous 6 month ; Provision sign informedconsent study protocol ; 18 &lt; Age &gt; 65 Women pregnant lactating ; Subject meet Inclusion criterion ; Recent and/or persistent visible blood sputum ( hemoptysis ) ; Rescue use oral antibiotic within previous 3 week , define antibiotic use health deterioration rather chronic suppression</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>iron</keyword>
	<keyword>hepcidin-25</keyword>
	<keyword>pulmonary exacerbation</keyword>
	<keyword>interleukin-6</keyword>
</DOC>